Press

Funding supports NemaLife’s development of new microbial products by harnessing its AI-powered high throughput in vivo discovery platform...

Check out Research Feature’s latest article written by our CEO, Siva Vanapalli, and Chairman of NemaLife’s Strategic Advisory Board,...

We’re thrilled to share that NutraIngredients has featured the NemaLife Discovery Flywheel and the Efficacy Matrix in their latest...

Concurrent Identification of Multiple Health Benefits Now Possible LUBBOCK, TX, UNITED STATES OF AMERICA, May 13, 2024 /EINPresswire.com/...

New provisional patent application for a rapid microfluidic in vivo assay enabling discovery of new gut health solutions for the functional

Loss of muscle mass and strength present a major challenge for astronauts on future long space voyages. Determining Muscle Strength in Space

NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...

NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...

To most, roundworms, or C. elegans, are just that: microscopic worms that live beneath our feet in the soil. But to scientists and...

Google investigates Worms in the Cloud: How nematodes and AI are transforming R&D.

The collaboration will support Motif's rapid food-technology product pipeline by utilizing in vivo testing for functional properties of...

NemaLife Inc., completed its DEA schedule 1 registration. If you have scheduled compounds (schedule 1-5) to test, reach out to our...

NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in...

Using AI, companies survey thousands of plant compounds to quickly and automatically identify potential ingredients for use in foods and...

Canopy Growth Corporation's Vice President of Human & Animal Research, Dr. Marcel Bonn-Miller is giving a talk about the long-term...

NemaLife Inc., completed its DEA schedule 2-5 registration. If you have scheduled compounds to test reach out to our expert for a free...

Loss of muscle mass and strength in astronauts remains an issue for space exploration. C. elegans shares common traits with humans and...

Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...

A microfluidic platform for long term culture and study of C. elegans Posted at 17:19h in Latest Research by Pouriya Bayat The short life...

Start-up NemaLife evolves from platform technology to services provider to identify chemicals that have both positive and negative...